Literature DB >> 23221517

Identification of collagen 1 as a post-transcriptional target of miR-29b in skin fibroblasts: therapeutic implication for scar reduction.

Jie Cheng1, Yanling Wang, Dongmiao Wang, Yunong Wu.   

Abstract

BACKGROUND: Excessive collagen synthesis and deposit during skin wound healing results in scar formation. MicroRNAs (miRNAs) are endogenous noncoding RNA regulators that mediate diverse biological functions through repressing target genes and hold great potentials for clinical therapeutic applications. The aim of the present study was to identify miRNAs as post-transcriptional regulators of collagen 1 in skin fibroblasts.
METHODS: miRNA candidates that potentially target collagen 1 were predicted by computational algorithms PicTar and TargetScan. The expression changes of collagen subunits 1α1 and 1α2 were measured by real-time reverse transcription-polymerase chain reaction and western blot after the primary skin fibroblasts were transfected with miR-29b mimics or inhibitor, respectively. A luciferase reporter assay was performed to further determine whether both collagen 1 subunits were probably direct targets of miR-29b.
RESULTS: Computational predictions identified several miRNAs as possible regulators for collagen 1 synthesis, including miR-29b. Enforced overexpression of miR-29b resulted in remarkable decrease of collagen 1α1 and 1α2, whereas knockdown of endogenous miR-29b induced pronounced increase of collagen 1α1 and 1α2 at both the messenger RNA and the protein levels. The luciferase activities were significantly inhibited when cells were cotransfected with reporter constructs and miR-29 mimics in vitro. Moreover, miR-29b transcriptional abundance inversely related to the levels of both collagen 1 subunits in skin scar as compared with normal skin.
CONCLUSIONS: Our data indicate that miR-29b is a potent post-transcriptional repressor of collagen 1 in skin fibroblasts and its deregulation might be implicated in scar formation, suggesting that miR-29b might represent a potential therapeutic target for scar reduction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23221517     DOI: 10.1097/MAJ.0b013e318267680d

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  21 in total

1.  miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.

Authors:  Christiane Gras; Dominica Ratuszny; Catarina Hadamitzky; Haijiao Zhang; Rainer Blasczyk; Constança Figueiredo
Journal:  Mol Med       Date:  2015-04-09       Impact factor: 6.354

Review 2.  The role of microRNAs in skin fibrosis.

Authors:  Olubukola Babalola; Andrew Mamalis; Hadar Lev-Tov; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2013-11       Impact factor: 3.017

3.  Biochemical and Biophysical Cues in Matrix Design for Chronic and Diabetic Wound Treatment.

Authors:  Yun Xiao; Samad Ahadian; Milica Radisic
Journal:  Tissue Eng Part B Rev       Date:  2016-08-19       Impact factor: 6.389

4.  miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Michael Vanden Oever; Daniel Muldoon; Wendy Mathews; Ron McElmurry; Jakub Tolar
Journal:  J Invest Dermatol       Date:  2016-06-18       Impact factor: 8.551

5.  Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.

Authors:  X Fan; J Xie; J Tian
Journal:  Cardiovasc Pharm Open Access       Date:  2017-01-31

6.  Molecular alterations due to Col5a1 haploinsufficiency in a mouse model of classic Ehlers-Danlos syndrome.

Authors:  Keren Machol; Urszula Polak; Monika Weisz-Hubshman; I-Wen Song; Shan Chen; Ming-Ming Jiang; Yuqing Chen-Evenson; Mary Ann E Weis; Douglas R Keene; David R Eyre; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2022-04-22       Impact factor: 5.121

7.  MicroRNA expression analysis of human skin fibroblasts treated with high-fluence light-emitting diode-red light.

Authors:  Andrew Mamalis; Eugene Koo; Clifford Tepper; Jared Jagdeo
Journal:  J Biophotonics       Date:  2019-02-01       Impact factor: 3.207

8.  The Mechanism of miR-222 Targets Matrix Metalloproteinase 1 in Regulating Fibroblast Proliferation in Hypertrophic Scars.

Authors:  Yi Zhang; Wei-Long Hong; Zhi-Ming Li; Qi-Yu Zhang; Kang Zeng
Journal:  Aesthetic Plast Surg       Date:  2020-04-29       Impact factor: 2.708

9.  Comparative Genomic, MicroRNA, and Tissue Analyses Reveal Subtle Differences between Non-Diabetic and Diabetic Foot Skin.

Authors:  Horacio A Ramirez; Liang Liang; Irena Pastar; Ashley M Rosa; Olivera Stojadinovic; Thomas G Zwick; Robert S Kirsner; Anna G Maione; Jonathan A Garlick; Marjana Tomic-Canic
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

Review 10.  Developing novel anti-fibrotic therapeutics to modulate post-surgical wound healing in glaucoma: big potential for small molecules.

Authors:  Cynthia Yu-Wai-Man; Peng Tee Khaw
Journal:  Expert Rev Ophthalmol       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.